Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sheraton Pentagon City Hotel

Mar 12, 2024 7:30 AM - Mar 13, 2024 3:55 PM

900 South Orme Street, Arlington, VA 22204, USA

Advertising and Promotion Regulatory Affairs Conference

Explore the current state of compliance for marketing both biopharmaceuticals and medical devices.

Session 10B: The Evolving World of Scientific Exchange

Session Chair(s)

Lynn  Bowen, PhD

Lynn Bowen, PhD

Vice President, Regulatory Affairs Advertising Promotion & Labeling

Alkermes, Inc., United States

The numerous and varied opportunities for scientific exchange (reactive and proactive) continue to introduce new challenges. This session aims to provide a regulatory background for these types of communications and discuss different examples of scientific exchange that various companies are currently participating in today, for example, medical booth activities, medical affairs activities, non-CME sponsored symposia, and more.

Learning Objective :
  • Describe the regulatory basis for scientific exchange
  • Evaluate different features of scientific exchange
  • Identify the different considerations in review of proactive scientific exchange

Speaker(s)

Lynn  Bowen, PhD

Scientific Exchange Mock Scenarios and Discussion

Lynn Bowen, PhD

Alkermes, Inc., United States

Vice President, Regulatory Affairs Advertising Promotion & Labeling

Heather  Banuelos, JD

Legal and Regulatory Framework for Scientific Exchange

Heather Banuelos, JD

King & Spalding LLP, United States

Counsel

Janet  Gottlieb, PhD

Proactive Medical Affairs Communications

Janet Gottlieb, PhD

Canopy Life Sciences, United States

Head of Medical Review Solutions

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.